Add to my calendar Prevention of Chronic Kidney Disease Progression
The talk will outline the new concept of applying a 4 pillar approach in the treatment of diabetic and non-diabetic patients with kidney disease, which just became available recently. With the publication of the FLOW study on may 24 last month, the 4 foundational therapies available consist of RASi, SGLT2i, nsMRA and GLP1-RA. Despite these overwhelming advances in halting or retarding CKD progression, implementation barriers of these treatments exist. Many patients driving on the path to kidney replacement therapy will not receive these treatments. The barriers will be discussed.

Christoph Wanner is a senior professor of medicine in the Department of Clinical Studies and Epidemiology, University Hospital of Würzburg and a visiting professor of renal medicine at the Nuffield Department of Population Health, Clinical Trial Service Unit, University of Oxford.
Date: 11 June 2024, 13:00
Venue: Richard Doll Building, Old Road Campus OX3 7LF
Venue Details: Richard Doll Lecture Theatre
Speakers: Speaker to be announced
Organising department: Nuffield Department of Population Health
Organiser: Graham Bagley (University of Oxford, Nuffield Department of Population Health)
Part of: Richard Doll Seminars
Booking required?: Not required
Audience: Members of the University only
Editor: Isobel Young